ARYx Therapeutics, Inc.

ARYX · OTC
Analyze with AI
9/30/2010
6/30/2010
3/31/2010
12/31/2009
Operating Activities
Net Income-$3-$4-$6-$6
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$2-$0-$1-$1
Other Non-Cash$0$0$0$0
Operating Cash Flow-$4-$4-$6-$6
Investing Activities
PP&E Inv.-$0$0$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$7
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$7
Financing Activities
Debt Repay.$5-$2-$1-$1
Stock Issued$0-$0$6$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$1
Financing Cash Flow$5-$2$5-$1
Forex Effect$0$0$0$0
Net Chg. in Cash$2-$5-$1$1
Supplemental Information
Beg. Cash$1$6$7$7
End Cash$3$1$6$7
Free Cash Flow-$4-$4-$6-$6
ARYx Therapeutics, Inc. (ARYX) Financial Statements & Key Stats | AlphaPilot